TY - JOUR
T1 - Expression of R-Spondin 1 in ApcMin/+ Mice Suppresses Growth of Intestinal Adenomas by Altering Wnt and Transforming Growth Factor Beta Signaling
AU - Lähde, Marianne
AU - Heino, Sarika
AU - Högström, Jenny
AU - Kaijalainen, Seppo
AU - Anisimov, Andrey
AU - Flanagan, Dustin
AU - Kallio, Pauliina
AU - Leppänen, Veli Matti
AU - Ristimäki, Ari
AU - Ritvos, Olli
AU - Wu, Katherine
AU - Tammela, Tuomas
AU - Hodder, Michael
AU - Sansom, Owen J.
AU - Alitalo, Kari
N1 - Funding Information:
Funding This work was funded by The Academy of Finland (Centre of Excellence Program 2014–2019 grant 273817, Translational Cancer Biology 307366, and the iCAN Flagship 2019-2022: grant 320185), Cancer Foundation Finland , Sigrid Juselius Foundation, Hospital District of Helsinki and Uusimaa, Helsinki Institute of Life Sciences, and Biocenter Finland (all to Kari Alitalo); The Finnish Medical Foundation , Biomedicum Helsinki Foundation (both to Marianne Lähde) and Cancer Foundation Finland (to Sarika Heino); and Cancer Research UK (grant A17196, to Dustin Flanagan and Owen J. Sansom). Tuomas Tammela is a Josie Robertson Scholar at the Sloan Kettering Institute and is supported by National Cancer Institute (grant R00CA187317) and the American Association for Cancer Research (grant 18-20-01-TAMM).
Funding Information:
Funding This work was funded by The Academy of Finland (Centre of Excellence Program 2014?2019 grant 273817, Translational Cancer Biology 307366, and the iCAN Flagship 2019-2022: grant 320185), Cancer Foundation Finland, Sigrid Juselius Foundation, Hospital District of Helsinki and Uusimaa, Helsinki Institute of Life Sciences, and Biocenter Finland (all to Kari Alitalo); The Finnish Medical Foundation, Biomedicum Helsinki Foundation (both to Marianne L?hde) and Cancer Foundation Finland (to Sarika Heino); and Cancer Research UK (grant A17196, to Dustin Flanagan and Owen J. Sansom). Tuomas Tammela is a Josie Robertson Scholar at the Sloan Kettering Institute and is supported by National Cancer Institute (grant R00CA187317) and the American Association for Cancer Research (grant 18-20-01-TAMM).The authors thank Dr Hans Clevers, Dr Pekka Katajisto, and Yaijing Gao for scientific advice; Dr Shentong Fang, Dr Saara Ollila, Simon Anderson, and Jennifer Paech for help with the experiments; and Mar?a Arrano de Kivikko, Tanja Laakkonen, Tapio Tainola, Katja Salo, David He, Tony Helenius, Vilja Jokinen, and Laura Amoedo Lopez for technical assistance. The authors also thank the Biomedicum Imaging Unit for microscopy services; Laboratory Animal Center of the University of Helsinki for technical assistance; Single Cell Analytics core facility at the Technology Centre of Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki supported by Biocenter Finland, for providing services and Genome Biology Unit supported by HiLIFE; and the Faculty of Medicine, University of Helsinki, and Biocenter Finland for providing slide scanning services. Marianne L?hde, MBBS (Conceptualization: Lead; Data curation: Lead; Formal analysis: Lead; Investigation: Lead; Methodology: Lead; Project administration: Lead; Software: Lead; Validation: Lead; Visualization: Lead; Writing ? original draft: Lead); Sarika Heino, MSc (Conceptualization: Supporting; Data curation: Supporting; Methodology: Supporting; Validation: Supporting; Visualization: Supporting; Writing ? review & editing: Supporting); Jenny H?gstr?m, PhD (Data curation: Supporting; Formal analysis: Supporting; Investigation: Supporting; Methodology: Supporting; Visualization: Supporting; Writing ? review & editing: Supporting); Seppo Kaijalainen, PhD (Methodology: Supporting); Andrey Anisimov, PhD (Methodology: Supporting); Dustin Flanagan, PhD (Data curation: Supporting); Pauliina Kallio, MD (Data curation: Supporting); Veli-Matti Lepp?nen, PhD (Methodology: Supporting); Ari Ristim?ki, MD, PhD (Formal analysis: Supporting); Olli Ritvos, MD, PhD (Methodology: Supporting); Katherine Wu, MSc (Data curation: Supporting); Tuomas Tammela, MD, PhD (Resources: Supporting; Writing ? review & editing: Supporting); Michael Hodder, PhD (Data curation: Supporting); Owen J. Sansom, PhD (Methodology: Supporting; Resources: Supporting; Writing ? review & editing: Supporting); Kari Alitalo, MD, Dr Med Sci (Conceptualization: Equal; Funding acquisition: Lead; Resources: Lead; Supervision: Lead; Writing ? review & editing: Lead).
Publisher Copyright:
© 2021 AGA Institute
PY - 2021/1/1
Y1 - 2021/1/1
N2 - Background & Aims: Mutations in the APC gene and other genes in the Wnt signaling pathway contribute to development of colorectal carcinomas. R-spondins (RSPOs) are secreted proteins that amplify Wnt signaling in intestinal stem cells. Alterations in RSPO genes have been identified in human colorectal tumors. We studied the effects of RSPO1 overexpression in ApcMin/+ mutant mice. Methods: An adeno associated viral vector encoding RSPO1-Fc fusion protein, or control vector, was injected into ApcMin/+mice. Their intestinal crypts were isolated and cultured as organoids. which were incubated with or without RSPO1-Fc and an inhibitor of transforming growth factor beta receptor (TGFBR). Livers were collected from mice and analyzed by immunohistochemistry. Organoids and adenomas were analyzed by quantitative reverse-transcription PCR, single cell RNA sequencing, and immunohistochemistry. Results: Intestines from Apc+/+ mice injected with the vector encoding RSPO1-Fc had significantly deeper crypts, longer villi, with increased EdU labeling, indicating increased proliferation of epithelial cells, in comparison to mice given control vector. AAV-RSPO1-Fc–transduced ApcMin/+ mice also developed fewer and smaller intestinal tumors and had significantly longer survival times. Adenomas of ApcMin/+ mice injected with the RSPO1-Fc vector showed a rapid increase in apoptosis and in the expression of Wnt target genes, followed by reduced expression of messenger RNAs and proteins regulated by the Wnt pathway, reduced cell proliferation, and less crypt branching than adenomas of mice given the control vector. Addition of RSPO1 reduced the number of adenoma organoids derived from ApcMin/+ mice and suppressed expression of Wnt target genes but increased phosphorylation of SMAD2 and transcription of genes regulated by SMAD. Inhibition of TGFBR signaling in organoids stimulated with RSPO1-Fc restored organoid formation and expression of genes regulated by Wnt. The TGFBR inhibitor restored apoptosis in adenomas from ApcMin/+ mice expressing RSPO1-Fc back to the same level as in the adenomas from mice given the control vector. Conclusions: Expression of RSPO1 in ApcMin/+ mice increases apoptosis and reduces proliferation and Wnt signaling in adenoma cells, resulting in development of fewer and smaller intestinal tumors and longer mouse survival. Addition of RSPO1 to organoids derived from adenomas inhibits their growth and promotes proliferation of intestinal stem cells that retain the APC protein; these effects are reversed by TGFB inhibitor. Strategies to increase the expression of RSPO1 might be developed for the treatment of intestinal adenomas.
AB - Background & Aims: Mutations in the APC gene and other genes in the Wnt signaling pathway contribute to development of colorectal carcinomas. R-spondins (RSPOs) are secreted proteins that amplify Wnt signaling in intestinal stem cells. Alterations in RSPO genes have been identified in human colorectal tumors. We studied the effects of RSPO1 overexpression in ApcMin/+ mutant mice. Methods: An adeno associated viral vector encoding RSPO1-Fc fusion protein, or control vector, was injected into ApcMin/+mice. Their intestinal crypts were isolated and cultured as organoids. which were incubated with or without RSPO1-Fc and an inhibitor of transforming growth factor beta receptor (TGFBR). Livers were collected from mice and analyzed by immunohistochemistry. Organoids and adenomas were analyzed by quantitative reverse-transcription PCR, single cell RNA sequencing, and immunohistochemistry. Results: Intestines from Apc+/+ mice injected with the vector encoding RSPO1-Fc had significantly deeper crypts, longer villi, with increased EdU labeling, indicating increased proliferation of epithelial cells, in comparison to mice given control vector. AAV-RSPO1-Fc–transduced ApcMin/+ mice also developed fewer and smaller intestinal tumors and had significantly longer survival times. Adenomas of ApcMin/+ mice injected with the RSPO1-Fc vector showed a rapid increase in apoptosis and in the expression of Wnt target genes, followed by reduced expression of messenger RNAs and proteins regulated by the Wnt pathway, reduced cell proliferation, and less crypt branching than adenomas of mice given the control vector. Addition of RSPO1 reduced the number of adenoma organoids derived from ApcMin/+ mice and suppressed expression of Wnt target genes but increased phosphorylation of SMAD2 and transcription of genes regulated by SMAD. Inhibition of TGFBR signaling in organoids stimulated with RSPO1-Fc restored organoid formation and expression of genes regulated by Wnt. The TGFBR inhibitor restored apoptosis in adenomas from ApcMin/+ mice expressing RSPO1-Fc back to the same level as in the adenomas from mice given the control vector. Conclusions: Expression of RSPO1 in ApcMin/+ mice increases apoptosis and reduces proliferation and Wnt signaling in adenoma cells, resulting in development of fewer and smaller intestinal tumors and longer mouse survival. Addition of RSPO1 to organoids derived from adenomas inhibits their growth and promotes proliferation of intestinal stem cells that retain the APC protein; these effects are reversed by TGFB inhibitor. Strategies to increase the expression of RSPO1 might be developed for the treatment of intestinal adenomas.
KW - Colon Cancer
KW - Familial Adenomatous Polyposis
KW - LGR5
KW - PROX1
UR - http://www.scopus.com/inward/record.url?scp=85097765723&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2020.09.011
DO - 10.1053/j.gastro.2020.09.011
M3 - Article
C2 - 32941878
AN - SCOPUS:85097765723
SN - 0016-5085
VL - 160
SP - 245
EP - 259
JO - Gastroenterology
JF - Gastroenterology
IS - 1
ER -